Cargando…

Does Pitavastatin Therapy for Patients with Type 2 Diabetes and Dyslipidemia Affect Serum Adiponectin Levels and Insulin Sensitivity?

(1) Background: We aimed to demonstrate the effects of pitvastatin therapy on the serum levels of total adiponectin and high-molecular-weight (HMW) adiponectin in type 2 diabetes and the correlation with insulin sensitivity. (2) Methods: This study was designed as an open-labelled randomized trial....

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jeongmin, Kim, Min-Hee, Lee, Jung-Min, Chang, Sang-Ah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692324/ https://www.ncbi.nlm.nih.gov/pubmed/36431233 http://dx.doi.org/10.3390/jcm11226756

Ejemplares similares

Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia
por: Sasaki, Jun
Publicado: (2010)

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
por: Saito, Yasushi
Publicado: (2009)

Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
por: Ohsawa, Masato, et al.
Publicado: (2015)

Role of insulin signaling impairment, adiponectin and dyslipidemia in peripheral and central neuropathy in mice
por: Anderson, Nicholas J., et al.
Publicado: (2014)

Comparison of Efficacy of Intensive versus Mild Pitavastatin Therapy on Lipid and Inflammation Biomarkers in Hypertensive Patients with Dyslipidemia
por: Yamasaki, Tomohiro, et al.
Publicado: (2014)

Pleiotropic effects of pitavastatin
por: Davignon, Jean
Publicado: (2012)

Reference of serum insulin level and prevalence of insulin resistance of Korean children and adolescents
por: Lim, Jung Sub, et al.
Publicado: (2013)

Serum Leptin and Adiponectin Levels in Korean Patients with Psoriasis
por: Oh, Yu Jin, et al.
Publicado: (2014)

Relationship between Serum Ferritin Levels and Dyslipidemia in Korean Adolescents
por: Kim, Young-Eun, et al.
Publicado: (2016)

The Relationship Between Serum Adiponectin, Tumor Necrosis Factor−Alpha, Leptin Levels and Insulin Sensitivity in Childhood and Adolescent Obesity: Adiponectin is a Marker of Metabolic Syndrome
por: Alikaşifoğlu, Ayfer, et al.
Publicado: (2009)

Pitavastatin Induces Cancer Cell Apoptosis by Blocking Autophagy Flux
por: Tilija Pun, Nirmala, et al.
Publicado: (2022)

Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients
por: Aleidi, Shereen, et al.
Publicado: (2015)

Interaction of the pitavastatin with model membranes
por: Shurshalova, Guzel S., et al.
Publicado: (2021)

Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA(2) in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome
por: Lee, Hyo-Sun, et al.
Publicado: (2016)

Clinical Implication of Serum Adiponectin Levels in Adult Patients with Atopic Dermatitis
por: Lee, Sul-Hee, et al.
Publicado: (2022)

Rosuvastatin Does Not Affect Fasting Glucose, Insulin Resistance, or Adiponectin in Patients with Mild to Moderate Hypertension
por: Kim, Weon, et al.
Publicado: (2013)

Association of serum free thyroxine and glucose homeostasis: Korea National Health and Nutrition Examination Survey
por: Ha, Jeonghoon, et al.
Publicado: (2021)

Hyperthyroidism-Associated Insulin Resistance Is Not Mediated by Adiponectin Levels
por: Chu, Chih-Hsun, et al.
Publicado: (2011)

Effects of eicosapentaenoic acid on serum levels of selenoprotein P and organ‐specific insulin sensitivity in humans with dyslipidemia and type 2 diabetes
por: Takeshita, Yumie, et al.
Publicado: (2021)

Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemia
por: Lee, Jeongmin, et al.
Publicado: (2023)

Association of Adiponectin Gene Polymorphism with Adiponectin Levels And Risk for Insulin Resistance Syndrome
por: Prakash, Jai, et al.
Publicado: (2015)

Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study
por: Wongprikorn, Asita, et al.
Publicado: (2016)

Serum and aqueous humor adiponectin levels correlate with diabetic retinopathy development and progression
por: Yang, Hyun Seung, et al.
Publicado: (2021)

Pitavastatin in cardiometabolic disease: therapeutic profile
por: Masana, Luis
Publicado: (2013)

Does dyslipidemia worsen the hearing level in diabetics?
por: Deepika, Pratap, et al.
Publicado: (2017)

Low Vitamin D Serum Level Is Associated with HDL-C Dyslipidemia and Increased Serum Thrombomodulin Levels of Insulin-Resistant Individuals
por: Saheb Sharif-Askari, Fatemeh, et al.
Publicado: (2020)

Increased Adipose and Muscle Insulin Sensitivity Without Changes in Serum Adiponectin in Young Female Collegiate Athletes
por: Kitaoka, Kaori, et al.
Publicado: (2017)

Effects of cold sensitivity in the extremities on circulating adiponectin levels and metabolic syndrome in women
por: Park, Ah Yeon, et al.
Publicado: (2017)

Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo
por: Cho, Yongin, et al.
Publicado: (2020)

Pitavastatin Compared with Differential Intervention Trial by Standard Therapy on Cardiovascular Events in Patients with Dyslipidemia on Chronic Hemodialysis (DIALYSIS): A Randomized Controlled Trial
por: Hamada, Chieko, et al.
Publicado: (2023)

Serum adiponectin and insulin secretion: A direct or inverse association?
por: Nakamura, Akinobu, et al.
Publicado: (2018)

Relationship between Adiponectin Level, Insulin Sensitivity, and Metabolic Syndrome in Type 1 Diabetic Patients
por: Blaslov, Kristina, et al.
Publicado: (2013)

Pitavastatin versus Atorvastatin: Potential Differences in their Effects on Serum Lipoprotein Lipase and Cardiovascular Disease
por: Kobayashi, Junji
Publicado: (2022)

Prevention of Cardiovascular Events with Pitavastatin is Associated with Increased Serum Lipoprotein Lipase Mass Level: Subgroup Analysis of the TOHO-LIP
por: Nagayama, Daiji, et al.
Publicado: (2022)

Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study
por: Lee, Hae-Young, et al.
Publicado: (2014)

The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples
por: Muratsu, Jun, et al.
Publicado: (2022)

Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level
por: Hwang, Y.-C., et al.
Publicado: (2011)

Statin on insulin and adiponectin levels: true or false prophecy?
por: Jonnalagadda, Venu Gopal, et al.
Publicado: (2018)

Pitavastatin: evidence for its place in treatment of hypercholesterolemia
por: Alagona, Peter
Publicado: (2010)

Effect of Pitavastatin on Vascular Reactivity in Hypercholesterolemic Rabbits
por: de Almeida, Eros Antonio, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_252fjs0cjmfo3a4l396qervd65